Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Ursula Schmidt-Erfurth; Paolo Lanzetta; Sebastian Wolf; Christian Simader; Erika Tokaji; Stefan Pilz; Annemarie Weisberger; Michael Larsen; MONT BLANC Study Group

doi:10.1016/j.ophtha.2012.02.002

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Ursula Schmidt-Erfurth, Paolo Lanzetta, Sebastian Wolf, Christian Simader, Erika Tokaji, Stefan Pilz, Annemarie Weisberger, Michael Larsen, MONT BLANC Study Group

Afdeling for Øjensygdomme HOC

130 Citationer (Scopus)

Abstract

To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.

Originalsprog	Engelsk
Tidsskrift	Ophthalmology
Vol/bind	119
Udgave nummer	5
Sider (fra-til)	992-1000
Antal sider	9
ISSN	0161-6420
DOI	https://doi.org/10.1016/j.ophtha.2012.02.002
Status	Udgivet - 2012

Adgang til dokumentet

10.1016/j.ophtha.2012.02.002

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{37cf7d9c69a1459bbc045934698e8f85,

title = "Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results",

abstract = "To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.",

keywords = "Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Choroidal Neovascularization, Combined Modality Therapy, Double-Blind Method, Female, Humans, Incidence, Macular Degeneration, Male, Middle Aged, Photochemotherapy, Photosensitizing Agents, Porphyrins, Prospective Studies, Treatment Outcome, Visual Acuity",

author = "Ursula Schmidt-Erfurth and Paolo Lanzetta and Sebastian Wolf and Christian Simader and Erika Tokaji and Stefan Pilz and Annemarie Weisberger and Michael Larsen and \{MONT BLANC Study Group\}",

year = "2012",

doi = "10.1016/j.ophtha.2012.02.002",

language = "English",

volume = "119",

pages = "992--1000",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration

T2 - twelve-month MONT BLANC study results

AU - Schmidt-Erfurth, Ursula

AU - Lanzetta, Paolo

AU - Wolf, Sebastian

AU - Simader, Christian

AU - Tokaji, Erika

AU - Pilz, Stefan

AU - Weisberger, Annemarie

AU - Larsen, Michael

AU - MONT BLANC Study Group

PY - 2012

Y1 - 2012

N2 - To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.

AB - To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.

KW - Aged

KW - Aged, 80 and over

KW - Angiogenesis Inhibitors

KW - Antibodies, Monoclonal, Humanized

KW - Choroidal Neovascularization

KW - Combined Modality Therapy

KW - Double-Blind Method

KW - Female

KW - Humans

KW - Incidence

KW - Macular Degeneration

KW - Male

KW - Middle Aged

KW - Photochemotherapy

KW - Photosensitizing Agents

KW - Porphyrins

KW - Prospective Studies

KW - Treatment Outcome

KW - Visual Acuity

UR - https://www.scopus.com/pages/publications/84860452217

U2 - 10.1016/j.ophtha.2012.02.002

DO - 10.1016/j.ophtha.2012.02.002

M3 - Journal article

C2 - 22424834

SN - 0161-6420

VL - 119

SP - 992

EP - 1000

JO - Ophthalmology

JF - Ophthalmology

IS - 5

ER -

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater